Atrás
48
27
También listada como
FLMNY
OTC
Rango del Día
$52.85
$52.90
Rango de 52 Semanas
$42.54
$64.00
Volumen
200
Promedio 50D / 200D
$57.63
/
$60.50
Cierre Anterior
$52.85
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 29.2 | 0.2 |
| P/B | 4.9 | 3.0 |
| ROE % | 18.0 | 3.6 |
| Net Margin % | 6.7 | 3.8 |
| Rev Growth 5Y % | 12.2 | 9.9 |
| D/E | 1.0 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$3.50
$3.41 – $3.57
|
2.93B | 6 |
| FY2028 |
$3.34
$3.26 – $3.41
|
2.86B | 7 |
| FY2027 |
$3.00
$2.93 – $3.07
|
2.71B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-06 | N/A | $0.73 | — |
| 2025-08-28 | N/A | $0.73 | — |
| 2025-04-28 | N/A | $0.68 | — |
| 2025-02-26 | N/A | $0.33 | — |
| 2024-11-01 | $0.70 | $0.47 | -32.9% |
| 2024-08-29 | $1.55 | $0.14 | -91.0% |
| 2024-04-30 | $1.55 | $0.14 | -91.0% |
| 2024-02-29 | $1.55 | $0.14 | -91.0% |
Dividend History
6 yr streakYield
0.02%
Payout Ratio
0.55%
Growth (3Y)
-8.48%
Growth (5Y)
-9.55%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jul 13, 2026 | Jul 14, 2026 | $1.20 | 2.27% |
| Jul 11, 2025 | Jul 15, 2025 | $1.35 | 2.10% |
| Jul 12, 2024 | Jul 16, 2024 | $1.17 | 2.44% |
| Jul 14, 2023 | Jul 18, 2023 | $0.88 | 1.61% |
| Jul 15, 2022 | Jul 19, 2022 | $1.76 | 3.25% |
| Jul 09, 2021 | Jul 13, 2021 | $1.40 | 1.61% |
| Jul 12, 2019 | Jul 16, 2019 | $2.22 | 2.99% |
| Jul 13, 2018 | Jul 17, 2018 | $2.17 | 2.61% |
| Jun 02, 2017 | Jun 07, 2017 | $2.11 | 2.66% |
| Jul 15, 2016 | — | $2.05 | 3.10% |
| Jul 10, 2015 | — | $1.87 | 2.83% |
| Jul 03, 2014 | — | $6.79 | 3.23% |
Puntos Clave
Revenue grew 12.19% annually over 5 years — strong growth
Earnings grew 21.90% over the past year
ROE of 17.99% — decent returns on equity
Generating 327.41M in free cash flow
Cash machine — converts 215.25% of earnings into free cash flow
Capital efficient — spends only 3.65% of revenue on capex
Crecimiento
Revenue Growth (5Y)
12.19%
Revenue (1Y)14.98%
Earnings (1Y)21.90%
FCF Growth (3Y)33.87%
Calidad
Return on Equity
17.99%
ROIC14.45%
Net Margin6.72%
Op. Margin15.09%
Seguridad
Debt / Equity
0.97
Current Ratio0.64
Interest Coverage8.16
Valoración
P/E Ratio
29.18
Forward P/E19.58
P/B Ratio4.94
EV/EBITDA15.27
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.98% | Revenue Growth (3Y) | 13.44% |
| Earnings Growth (1Y) | 21.90% | Earnings Growth (3Y) | 21.14% |
| Revenue Growth (5Y) | 12.19% | Earnings Growth (5Y) | 6.92% |
| Profitability | |||
| Revenue (TTM) | 2.26B | Net Income (TTM) | 152.11M |
| ROE | 17.99% | ROA | 6.42% |
| Gross Margin | 80.02% | Operating Margin | 15.09% |
| Net Margin | 6.72% | Free Cash Flow (TTM) | 327.41M |
| ROIC | 14.45% | FCF Growth (3Y) | 33.87% |
| Safety | |||
| Debt / Equity | 0.97 | Current Ratio | 0.64 |
| Interest Coverage | 8.16 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 0.55% |
| Dividend Growth (3Y) | -8.48% | Dividend Growth (5Y) | -9.55% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 29.18 | Forward P/E | 19.58 |
| P/B Ratio | 4.94 | P/S Ratio | 1.96 |
| PEG Ratio | 1.06 | Forward PEG | N/A |
| EV/EBITDA | 15.27 | Fwd EV/EBITDA | 10.03 |
| Forward P/S | 1.73 | Fwd Earnings Yield | 5.11% |
| FCF Yield | 7.38% | ||
| Market Cap | 4.44B | Enterprise Value | 5.22B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2.26B | 1.97B | 1.76B | 1.68B | 1.43B |
| Net Income | 152.11M | 124.79M | 103.66M | 136.86M | 116.41M |
| EPS (Diluted) | 1.81 | 1.49 | 1.23 | 1.63 | 1.39 |
| Gross Profit | 1.81B | 1.57B | 1.38B | 1.34B | 1.15B |
| Operating Income | 341.68M | 648.84M | 575.63M | 583.61M | 179.23M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2.37B | 2.02B | 1.77B | 1.74B | 1.67B |
| Total Liabilities | 1.46B | 1.06B | 913.48M | 863.09M | 832.86M |
| Shareholders' Equity | 899.13M | 792.03M | 804.22M | 819.83M | 779.20M |
| Total Debt | 873.85M | 592.15M | 505.66M | 458.26M | 425.72M |
| Cash & Equivalents | 94.29M | 58.93M | 51.25M | 174.89M | 103.72M |
| Current Assets | 545.62M | 510.40M | 489.95M | 538.32M | 518.18M |
| Current Liabilities | 846.71M | 529.51M | 391.79M | 366.29M | 356.30M |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#442 of 1049
Custom
Balanced Risk
#145 of 153
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Balanced Risk
Mar 24, 2026